Erasca Inc (NASDAQ:ERAS)’s traded shares stood at 1.43 million during the last session, with the company’s beta value hitting 1.20. At the close of trading, the stock’s price was $2.81, to imply a decrease of -1.40% or -$0.04 in intraday trading. The ERAS share’s 52-week high remains $3.45, putting it -22.78% down since that peak but still an impressive 46.26% since price per share fell to its 52-week low of $1.51. The company has a valuation of $794.46M, with an average of 1.74 million shares in intraday trading volume over the past 10 days and average of 1.92 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Erasca Inc (ERAS), translating to a mean rating of 1.29. Of 3 analyst(s) looking at the stock, 0 analyst(s) give ERAS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.14.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Erasca Inc (NASDAQ:ERAS) trade information
After registering a -1.40% downside in the last session, Erasca Inc (ERAS) has traded red over the past five days. The 5-day price performance for the stock is -9.65%, and -1.40% over 30 days. With these gigs, the year-to-date price performance is 31.92%. Short interest in Erasca Inc (NASDAQ:ERAS) saw shorts transact 32.97 million shares and set a 23.89 days time to cover.
The extremes give us $7 and $7 for target low and target high price respectively. As such, ERAS has been trading -149.11% off suggested target high and -149.11% from its likely low.
Erasca Inc (ERAS) estimates and forecasts
Looking at statistics comparing Erasca Inc share performance against respective industry, we note that the company has underperformed competitors. Erasca Inc (ERAS) shares are 51.89% up over the last 6 months, with its year-to-date growth rate lower than industry average at -8.43% against 16.90%. Revenue is forecast to grow 28.64% this quarter before jumping 39.13% for the next one.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -69.36% for the past 5-year period. While 2024 is set for a 3.22% return in earnings, projections for the next 5 years are at -4.10% annually.
ERAS Dividends
Erasca Inc has its next earnings report out in December. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Erasca Inc (NASDAQ:ERAS)’s Major holders
Erasca Inc insiders hold 12.39% of total outstanding shares, with institutional holders owning 80.54% of the shares at 91.92% float percentage. In total, 80.54% institutions holds shares in the company, led by VR ADVISER, LLC. As of 2024-06-30, the company held over 16.22 million shares (or 7.4452% of shares), all amounting to roughly $38.27 million.
The next major institution holding the largest number of shares is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. with 16.22 million shares, or about 7.4452% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $38.27 million.
